anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Table

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 60,568
Current window 46,081-46,110
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all
18 30 60

Component

46,081-46,110 of 60,568

filter-aware
24
The slide uses a standard clinical trial pipeline table format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
25
The slide uses a standard clinical trial registry format for reporting pipeline progress.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
26
The slide uses a standard clinical trial registry format for portfolio tracking.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
27
The slide is part of an appendix, specifically detailing clinical trial status for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
28
The slide provides a structured overview of four specific clinical trials (LAURA, ADAURA2, NeoADAURA, FLAURA2).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
29
The slide provides a structured overview of five specific clinical trials (SAFFRON, SANOVO, SACHI, SAVANNAH, ORCHARD) including patient counts and trial arms.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
30
The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
31
The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
32
The slide is part of an appendix, indicated by the footer and the 'Appendix' label.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
33
The slide is part of an appendix, specifically detailing late-stage development assets in Oncology.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
34
The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
35
The slide is part of an appendix section, indicated by the page number and glossary link.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
36
The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
37
The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
38
Includes trial identifiers (NCT numbers) and status timelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
39
The slide is an appendix page detailing clinical trial pipeline data for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
40
The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
41
The slide is part of an appendix section detailing clinical trial pipelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
42
The slide is part of an appendix, specifically detailing late-stage development assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
43
The slide is part of an appendix, providing detailed clinical trial data for a specific asset.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
44
The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
45
The slide is part of an appendix, providing specific clinical trial data for a drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
46
The slide is an appendix page detailing the clinical development pipeline for a specific drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
47
Slide 47 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
49
Slide 49 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
50
Part of a pipeline appendix deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
51
Slide 51 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
52
Part of a larger portfolio deck, indicated by the vertical navigation bar on the right.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
53
The slide is part of an appendix, providing detailed clinical trial data for a specific drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
54
Slide 54 of a larger deck, part of the appendix.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit